Evolva deploys our technologies, and our “bring to market” capabilities, on behalf of leading companies around the world. We help our partners to develop innovative ingredients and products, as well as to improve their operational efficiency. Some of our partnerships are described below.
We aspire to be a committed, innovative, fair and transparent partner that delivers. Please drop us an email, or give us a call if you have an interest in discussing what we could do for you.
No two partnerships are identical and we approach all partnership discussions in a flexible manner. However, one thing remains constant for all of them: our aim to make the collaboration “as good as it can be” for both partners. We believe that strong partnerships require:
- Aligned incentives and a shared commitment to make the relationship work
- Open and active communication channels
- A shared understanding of both the commercial potential and the commercial and technical risks
- A shared commitment to flexibility. R&D programs normally spring surprises (both good AND bad) and markets can be relied on to change whilst the R&D is going on
|In March 2015, Evolva and Valent BioSciences (www.valent.com) partnered to co-develop and commercialise a class of ingredients for use as next-generation agricultural bioactives. Evolva is responsible for R&D and Valent for commercialisation. The first products are expected to be launched in 2019-2020. More information on this collaboration and ingredient can be found here.|
|In early 2015, Evolva and Takasago (www.takasago.com) entered a collaboration to develop fermentation routes for several flavour and fragrance ingredients. Evolva has primary responsibility for R&D, scale-up and manufacturing whilst Takasago handles regulatory approvals and commercialisation. More information on this collaboration and ingredient can be found here.|
|In early 2014, Evolva partnered with L’Oréal (www.loreal.com) to co-develop an ingredient with broad applications in cosmetics. Evolva has primary responsibility for strain development and L’Oreal for applications work. More information on this collaboration and ingredient can be found here.|
|Since March 2013 we have been working with Cargill (www.cargill.com) to develop and commercialize better tasting stevia ingredients. Evolva is responsible for the strain development, and Cargill for everything else. Evolva has an option to have up to 45% of the final business. More information on this collaboration and ingredient can be found here. In January 2015, we started a second program with Cargill on an unrelated family of high-value food and beverage ingredients.|
|In January 2013, we partnered with Ajinomoto (www.ajinomoto.com) to develop a new production route for a natural ingredient of use in personal care. More information on this collaboration and ingredient can be found here. The first R&D phase in this project was completed successfully in March 2015.|
|At the start of 2012, we started a collaboration with Roquette (www.roquette.com) to optimize the production of an important food ingredient. The program is expected to be completed in summer 2015. More information on this collaboration and ingredient can be found here|
|In March 2011, Evolva commenced work with BASF (www.basf.com) to develop production routes to certain ingredients that are naturally made by Ergot, and that have potential use in crop protection. In 2013 Evolva delivered a yeast strain that could make the desired ingredients to BASF, and BASF is now advancing the ingredients through testing. More information on this collaboration and ingredient can be found here.|
|In January 2011 Evolva started working with International Flavors & Fragrances (www.iff.com) to develop a fermentation route for vanillin. The product was launched in summer 2014. More information on this collaboration and ingredient can be found here.|